7beta-Hydroxyepiandrosterone

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug Name7beta-Hydroxyepiandrosterone
Drug Alias Name7β-OH-EPIA7beta-OH-EpiA7β-Hydroxy-EpiandrosteroneHF-0220
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor antagonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited KingdomIndia
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNewron Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHunter-Fleming Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A